Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report.

Galié E, Renna R, Plantone D, Pace A, Marino M, Jandolo B, Koudriavtseva T.

Oncol Lett. 2016 Oct;12(4):2716-2719. Epub 2016 Jul 29.

2.

Multiple sclerosis activated by anti-tumor necrosis factor α (Etanercept) and the genetic risk.

Galiè E, Jandolo B, Martayane A, Renna R, Koudriavtseva T.

Neurol India. 2016 Sep-Oct;64(5):1042-4. doi: 10.4103/0028-3886.190240. No abstract available.

3.

A possible case of Hashimoto's encephalopathy after surgery and radiometabolic therapy for thyroid carcinoma.

Onesti E, Koudriavtseva T, Galiè E, Anelli V, Jandolo B.

Neurol Sci. 2013 Aug;34(8):1489-91. doi: 10.1007/s10072-012-1234-3. Epub 2012 Nov 17. No abstract available.

PMID:
23161258
4.

The importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of multiple sclerosis patients with mild and moderate disability.

Koudriavtseva T, Onesti E, Pestalozza IF, Sperduti I, Jandolo B.

Neurol Sci. 2012 Jun;33(3):575-84. doi: 10.1007/s10072-011-0776-0. Epub 2011 Sep 17.

PMID:
21927880
5.

In reference to Usery JB et al. (J Neuro-oncol. 2010 Feb 10).

Maschio M, Dinapoli L, Jandolo B.

J Neurooncol. 2010 Dec;100(3):491-2. doi: 10.1007/s11060-010-0203-z. Epub 2010 May 12. No abstract available.

PMID:
20461444
6.

Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.

Pace A, Giannarelli D, Galiè E, Savarese A, Carpano S, Della Giulia M, Pozzi A, Silvani A, Gaviani P, Scaioli V, Jandolo B, Bove L, Cognetti F.

Neurology. 2010 Mar 2;74(9):762-6. doi: 10.1212/WNL.0b013e3181d5279e.

PMID:
20194916
7.

Fatal herpetic encephalitis during brain radiotherapy in a cerebral metastasized breast cancer patient.

Koudriavtseva T, Onesti E, Tonachella R, Pelagalli L, Vidiri A, Jandolo B.

J Neurooncol. 2010 Oct;100(1):137-40. doi: 10.1007/s11060-010-0134-8. Epub 2010 Feb 11.

PMID:
20148285
8.

Bilateral whirlbone necrosis in a young multiple sclerosis patient.

Galiè E, Jandolo B.

Neurol Sci. 2010 Apr;31(2):197-8. doi: 10.1007/s10072-009-0177-9.

PMID:
20066553
9.

Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy.

Maschio M, Dinapoli L, Gomellini S, Ferraresi V, Sperati F, Vidiri A, Muti P, Jandolo B.

J Neurooncol. 2010 May;98(1):109-16. doi: 10.1007/s11060-009-0069-0. Epub 2009 Nov 24.

PMID:
19937087
10.

Sexual dysfunction following surgery for rectal cancer - a clinical and neurophysiological study.

Pietrangeli A, Pugliese P, Perrone M, Sperduti I, Cosimelli M, Jandolo B.

J Exp Clin Cancer Res. 2009 Sep 17;28:128. doi: 10.1186/1756-9966-28-128.

11.

Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.

Maschio M, Dinapoli L, Saveriano F, Pompili A, Carapella CM, Vidiri A, Jandolo B.

Acta Neurol Scand. 2009 Sep;120(3):210-2. doi: 10.1111/j.1600-0404.2009.01226.x.

PMID:
19719809
12.

Reversible erectile dysfunction in a patient with brain tumor-related epilepsy in therapy with zonisamide in add-on.

Maschio M, Saveriano F, Dinapoli L, Jandolo B.

J Sex Med. 2011 Dec;8(12):3515-7. doi: 10.1111/j.1743-6109.2009.01373.x. Epub 2009 Jun 29.

PMID:
19570041
13.

The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine.

Maschio M, Dinapoli L, Vidiri A, Pace A, Fabi A, Pompili A, Carapella MC, Jandolo B.

J Exp Clin Cancer Res. 2009 May 6;28:60. doi: 10.1186/1756-9966-28-60.

14.

Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study.

Dinapoli L, Maschio M, Jandolo B, Fabi A, Pace A, Sperati F, Muti P.

Neurol Sci. 2009 Aug;30(4):353-9. doi: 10.1007/s10072-009-0087-x. Epub 2009 May 5.

PMID:
19415165
15.

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation.

Fabi A, Metro G, Russillo M, Vidiri A, Carapella CM, Maschio M, Cognetti F, Jandolo B, Mirri MA, Sperduti I, Telera S, Carosi M, Pace A.

BMC Cancer. 2009 Mar 31;9:101. doi: 10.1186/1471-2407-9-101.

16.

End of life issues in brain tumor patients.

Pace A, Di Lorenzo C, Guariglia L, Jandolo B, Carapella CM, Pompili A.

J Neurooncol. 2009 Jan;91(1):39-43. doi: 10.1007/s11060-008-9670-x. Epub 2008 Aug 14. Erratum in: J Neurooncol. 2009 Jan;91(1):45. Lorenzo, Cherubino Di [corrected to Di Lorenzo, Cherubino].

PMID:
18704267
17.

Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.

Maschio M, Albani F, Jandolo B, Zarabla A, Contin M, Dinapoli L, Fabi A, Pace A, Baruzzi A.

J Neurooncol. 2008 Nov;90(2):217-21. doi: 10.1007/s11060-008-9651-0. Epub 2008 Jul 9.

PMID:
18612799
18.

In reference to Bosma et al. The course of neurocognitive functioning in high-grade glioma patients.

Maschio M, Dinapoli L, Zarabla A, Jandolo B.

Neuro Oncol. 2008 Feb;10(1):106-7. doi: 10.1215/15228517-2007-049. Epub 2008 Jan 8. No abstract available.

19.

Outcome and tolerability of topiramate in brain tumor associated epilepsy.

Maschio M, Dinapoli L, Zarabla A, Pompili A, Carapella CM, Pace A, Giannarelli D, Occhipinti E, Jandolo B.

J Neurooncol. 2008 Jan;86(1):61-70. Epub 2007 Jun 28.

PMID:
17598071
20.

Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue?

Pace A, Nisticò C, Cuppone F, Bria E, Galiè E, Graziano G, Natoli G, Sperduti I, Jandolo B, Calabretta F, Tomao S, Terzoli E.

Clin Breast Cancer. 2007 Apr;7(7):550-4.

PMID:
17509163
21.

Early post-operative MRI: correlation with progression-free survival and overall survival time in malignant gliomas.

Vidiri A, Carapella CM, Pace A, Mirri A, Fabi A, Carosi M, Giannarelli D, Pompili A, Jandolo B, Occhipinti E, Di Giovanni S, Crecco M.

J Exp Clin Cancer Res. 2006 Jun;25(2):177-82.

PMID:
16918127
22.

Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up.

Pietrangeli A, Leandri M, Terzoli E, Jandolo B, Garufi C.

Eur Neurol. 2006;56(1):13-6. Epub 2006 Jul 3.

PMID:
16825773
23.

Issues related to the pharmacological management of patients with brain tumours and epilepsy.

Maschio M, Dinapoli L, Zarabia A, Jandolo B.

Funct Neurol. 2006 Jan-Mar;21(1):15-9. Review.

PMID:
16734997
24.

Levetiracetam therapy in patients with brain tumour and epilepsy.

Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B.

J Neurooncol. 2006 Oct;80(1):97-100. Epub 2006 May 10.

PMID:
16685465
25.

Cerebellar atrophy and monoclonal gammopathy of undetermined significance: a possible correlation?

Galiè E, Maschio M, Jandolo B.

J Exp Clin Cancer Res. 2005 Sep;24(3):483-5.

PMID:
16270536
26.

Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.

Pace A, Bove L, Jandolo B.

Neurology. 2005 Aug 9;65(3):501-2; author reply 501-2. No abstract available.

PMID:
16087937
27.

Supportive therapy in neuro-oncology.

Maschio M, Jandolo B.

J Exp Clin Cancer Res. 2005 Mar;24(1):17-24. Review.

PMID:
15943027
28.

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.

Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B, Carapella CM.

Ann Oncol. 2003 Dec;14(12):1722-6.

PMID:
14630675
29.

The diagnostic importance of the isolated supranuclear downward gaze ophthalmoplegia in progressive supranuclear palsy.

Brusa A, Bentivoglio AR, Calzetti S, Cammarata S, Congia S, Fasano A, Jandolo B, Lucci B, Primavera A, Stoehr R.

Neurol Sci. 2003 Oct;24(3):161. No abstract available.

PMID:
14598066
30.

Demyelinating disease in monoclonal gammopathy of undetermined significance.

Galiè E, Pietrangeli A, Maschio M, Pace A, Vidiri A, Carosi M, Jandolo B.

J Exp Clin Cancer Res. 2003 Jun;22(2):337-9.

PMID:
12866587
31.

Masseteric silent period and reflex before and after dentomaxillofacial surgery.

Jandolo B, Galiè E, Badia D.

Neurol Sci. 2003 Jun;24(2):53-6.

PMID:
12827538
32.

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L.

J Clin Oncol. 2003 Mar 1;21(5):927-31.

PMID:
12610195
33.

Quality-of-life assessment in patients who had been surgically treated for cerebellar pilocytic astrocytoma in childhood.

Pompili A, Caperle M, Pace A, Ramazzotti V, Raus L, Jandolo B, Occhipinti E.

J Neurosurg. 2002 Feb;96(2):229-34.

PMID:
11838795
34.

A pilot study on the relation between cisplatin neuropathy and vitamin E.

Bove L, Picardo M, Maresca V, Jandolo B, Pace A.

J Exp Clin Cancer Res. 2001 Jun;20(2):277-80.

PMID:
11484987
35.

Brachial plexus neuropathy as unusual onset of diffuse neurolymphomatosis.

Pietrangeli A, Milella M, De Marco S, Bartolazzi A, Mottolese M, Zompetta C, Jandolo B.

Neurol Sci. 2000 Aug;21(4):241-5.

PMID:
11214664
36.

Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.

De Santis S, Pace A, Bove L, Cognetti F, Properzi F, Fiore M, Triaca V, Savarese A, Simone MD, Jandolo B, Manzione L, Aloe L.

Clin Cancer Res. 2000 Jan;6(1):90-5.

37.

Cytomegalovirus encephalitis: diagnosis with clinical approach, EEG and PCR techniques.

Maschio M, Giudiceandrea F, Contadini P, Jandolo B.

Ital J Neurol Sci. 1999 Aug;20(4):255-8.

PMID:
10551914
38.

Epilepsy and gliomas: incidence and treatment in 119 patients.

Pace A, Bove L, Innocenti P, Pietrangeli A, Carapella CM, Oppido P, Raus L, Occhipinti E, Jandolo B.

J Exp Clin Cancer Res. 1998 Dec;17(4):479-82.

PMID:
10089071
39.

Neurophysiological evaluation of sexual dysfunction in patients operated for colorectal cancer.

Pietrangeli A, Bove L, Innocenti P, Pace A, Tirelli C, Santoro E, Jandolo B.

Clin Auton Res. 1998 Dec;8(6):353-7.

PMID:
9869554
40.

Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients.

Pace A, Bove L, Aloe A, Nardi M, Pietrangeli A, Calabresi F, Innocenti P, Jandolo B.

Ital J Neurol Sci. 1997 Apr;18(2):73-9.

PMID:
9239526
41.

Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients.

Pace A, Bove L, Nisticò C, Ranuzzi M, Innocenti P, Pietrangeli A, Terzoli E, Jandolo B.

J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):409-11.

42.

Docetaxel neuropathy.

Pace A, Bove L, Pietrangeli A, Innocenti P, Jandolo B.

Neurology. 1996 Aug;47(2):615. No abstract available.

PMID:
8757066
43.

Neurophysiological examination of end-plate function in patients with lung cancer.

Jandolo B, Della Giulia M, Pace A, Pietrangeli A, Bove L, Innocenti P, Lopez M.

Electromyogr Clin Neurophysiol. 1995 Jun-Jul;35(4):247-50.

PMID:
7555930
44.

Neurotoxicity of antitumoral IL-2 therapy: evoked cognitive potentials and brain mapping.

Pace A, Pietrangeli A, Bove L, Rosselli M, Lopez M, Jandolo B.

Ital J Neurol Sci. 1994 Oct;15(7):341-6.

PMID:
7698891
45.

Brain-stem auditory evoked potentials in supratentorial brain tumors.

Jandolo B, Pietrangeli A, Pace A, Carapella CM, Finocchiaro R, Morace E.

Electromyogr Clin Neurophysiol. 1992 Jun;32(6):307-9.

PMID:
1623847
46.

The VEP in evaluation of pituitary tumors.

Pietrangeli A, Jandolo B, Occhipinti E, Carapella CM, Morace E.

Electromyogr Clin Neurophysiol. 1991 Apr;31(3):163-5.

PMID:
2049991
47.

The effect of brain radiotherapy on the P3 component of ERP's.

Pietrangeli A, Finocchiaro R, Pace A, Rinaldi M, Jandolo B.

J Neurosurg Sci. 1990 Jul-Dec;34(3-4):327-8.

PMID:
2098515
48.

Lonidamine in the combined treatment of malignant gliomas. A randomized study.

Carapella CM, Paggi MG, Calvosa F, Cattani F, Jandolo B, Mastrostefano R, Raus L, Riccio A.

J Neurosurg Sci. 1990 Jul-Dec;34(3-4):261-4.

PMID:
2098504
49.

Silent period in spinal cord pathology.

Jandolo B, Pietrangeli A, Morace E, Carapella C, Pascucci P.

Electromyogr Clin Neurophysiol. 1989 Apr;29(3):139-43.

PMID:
2721426
50.

Anterior interosseous nerve syndrome.

Gessini L, Jandolo B, Landucci C, Pietrangeli A.

Ital J Neurol Sci. 1988 Feb;9(1):41-5.

PMID:
2833463

Supplemental Content

Loading ...
Support Center